Cell Growth & Differentiation, Vol 4, Issue 7 603-609, Copyright © 1993 by American Association of Cancer Research

ARTICLES

Protein tyrosine phosphorylation and activation of primary response genes by interleukin 11 in B9-TY1 cells

T Yin and YC Yang
Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis 46202.

Interleukin (IL) 11 is a multifunctional cytokine derived from bone marrow stromal cells. To understand the mechanisms by which IL-11 exerts its pleiotropic actions, we have analyzed IL-11-mediated signal transduction pathways in IL-11-dependent B9-TY1, which is a subclone of an IL-6-dependent B-cell hybridoma, B9. IL-11 stimulation of B9-TY1 cells resulted in tyrosine phosphorylation of a 97/95 kilodalton cellular protein in a dose-dependent manner, and this effect was inhibited by tyrosine kinase inhibitors genistein and herbimycin A, but not by a serine/threonine kinase inhibitor, H7. We next examined the early nuclear events in the IL-11-triggered intracellular signaling cascade. The data showed that tis11, tis21, and junB early response genes were rapidly activated following IL-11 treatment. The kinetic studies indicated that activation of tis11 and junB genes peaked at 30-60 min and then declined slowly afterward. The tis21 gene was constitutively expressed, and the level of tis21 mRNA was significantly increased and maintained at the elevated level following IL-11 stimulation. Inhibitor studies with genistein, herbimycin A, and H7 revealed that tyrosine kinases and H7-sensitive serine/threonine kinases are required for the IL-11-mediated activation of tis11, tis21, and junB genes. Using a variety of known protein kinase inhibitors or activators, we have demonstrated that H7-sensitive protein kinases activated by IL-11 are distinct from those of well-characterized protein kinase-second messenger systems.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				N. Underhill-Day, L. A. McGovern, N. Karpovich, H. J. Mardon, V. A. Barton, and J. K. Heath Functional Characterization of W147A: A High-Affinity Interleukin-11 Antagonist Endocrinology, August 1, 2003; 144(8): 3406 - 3414. [Abstract] [Full Text] [PDF]

				K F Chung and P J Barnes Cytokines in asthma Thorax, September 1, 1999; 54(9): 825 - 857. [Full Text]

				E. Kumahara, T. Ebihara, and D. Saffen Protein Kinase Inhibitor H7 Blocks the Induction of Immediate-Early Genes zif268 and c-fos by a Mechanism Unrelated to Inhibition of Protein Kinase C but Possibly Related to Inhibition of Phosphorylation of RNA Polymerase II J. Biol. Chem., April 9, 1999; 274(15): 10430 - 10438. [Abstract] [Full Text] [PDF]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]

				X. Du and D. A. Williams Interleukin-11: Review of Molecular, Cell Biology, and Clinical Use Blood, June 1, 1997; 89(11): 3897 - 3908. [Full Text] [PDF]

				P. Neddermann, R. Graziani, G. Ciliberto, and G. Paonessa Functional Expression of Soluble Human Interleukin-11 (IL-11) Receptor alpha and Stoichiometry of in Vitro IL-11 Receptor Complexes with gp130 J. Biol. Chem., November 29, 1996; 271(48): 30986 - 30991. [Abstract] [Full Text] [PDF]